<SEC-DOCUMENT>0001140361-24-028719.txt : 20240604
<SEC-HEADER>0001140361-24-028719.hdr.sgml : 20240604
<ACCEPTANCE-DATETIME>20240604085243
ACCESSION NUMBER:		0001140361-24-028719
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20240530
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240604
DATE AS OF CHANGE:		20240604

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SEALED AIR CORP/DE
		CENTRAL INDEX KEY:			0001012100
		STANDARD INDUSTRIAL CLASSIFICATION:	PLASTIC MATERIAL, SYNTH RESIN/RUBBER, CELLULOS (NO GLASS) [2820]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				650654331
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12139
		FILM NUMBER:		241016176

	BUSINESS ADDRESS:	
		STREET 1:		2415 CASCADE POINTE BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28208
		BUSINESS PHONE:		980-221-3235

	MAIL ADDRESS:	
		STREET 1:		2415 CASCADE POINTE BOULEVARD
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	WR GRACE & CO/DE
		DATE OF NAME CHANGE:	19961015

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GRACE HOLDING INC
		DATE OF NAME CHANGE:	19960805
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ef20030540_8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2023" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:cef="http://xbrl.sec.gov/cef/2023" xmlns:see="http://sealedair.com/20240530" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Summit, a Broadridge Company
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html"/>
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_cd050f34584143cb822fcb7435edfdec" contextRef="c20240530to20240530" format="ixt:fixed-false">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_7f45b632db45453a92f028832bb8776e" contextRef="c20240530to20240530">SEALED AIR CORP/DE</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_4e6d4ad0a45844988d6e006f1d3961b4" contextRef="c20240530to20240530">0001012100</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="see-20240530.xsd" xlink:type="simple"/></ix:references><ix:resources><xbrli:context id="c20240530to20240530"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001012100</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-05-30</xbrli:startDate><xbrli:endDate>2024-05-30</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div><span style="font-size: 10pt;"> </span></div>

  <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/>
  <div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">UNITED STATES</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"> <br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 12pt; font-weight: bold;">Washington, D.C. 20549</div>

    <div style="font-size: 10pt;">
<div>&#160;
      </div>
<hr style="height: 2px; width: 18%; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 18pt;"><span style="font-size: 18pt; font-family: 'Times New Roman'; font-weight: bold;">FORM </span><span style="font-weight: bold;"><ix:nonNumeric name="dei:DocumentType" id="Fact_cc29206ea04f4902b0f2e80083f9ef23" contextRef="c20240530to20240530">8-K</ix:nonNumeric></span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">Date of Report (Date of earliest event reported): </span><ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_f4cd9a6b3a6f47bbac3c4cfe68a7853d" contextRef="c20240530to20240530" format="ixt:date-monthname-day-year-en">May 30, 2024</ix:nonNumeric></div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 24pt; font-weight: bold;"><span style="-sec-ix-hidden:Fact_7f45b632db45453a92f028832bb8776e">SEALED AIR CORPORATION</span><br/>
    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Exact name of registrant as specified in its charter)</div>

    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33.23%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_194e8c3f3c324d029b913fb5272438f7" contextRef="c20240530to20240530" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 34%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_e9ef2d9424a647ffb74557943e9cb84e" contextRef="c20240530to20240530">1-12139</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 33.39%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_bee8c5de846740818e51ee63e4bd8099" contextRef="c20240530to20240530">65-0654331</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33.23%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(State or other jurisdiction of incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(Commission File Number)</div>
          </td>

    <td style="width: 33.39%; vertical-align: bottom;">
            <div style="text-align: center; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">(IRS Employer Identification No.)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 49%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_72b4b5052eca40899cfffe80ce6a7b4c" contextRef="c20240530to20240530">2415 Cascade Pointe Boulevard</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td rowspan="1" style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_51889b36dffa4ab78cff6592a440201a" contextRef="c20240530to20240530">Charlotte</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_f56669ae1cfc4a5497ddadc983b674d1" contextRef="c20240530to20240530" format="ixt-sec:stateprovnameen">North Carolina</ix:nonNumeric></div>
          </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_8b7276c613054df180fd85109bfbf029" contextRef="c20240530to20240530">28208</ix:nonNumeric><br/>
            </div>
          </td>

  </tr>

  <tr>

    <td style="vertical-align: top; font-size: 10pt; width: 49%;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Address of principal executive offices)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 49%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div style="text-align: left;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">Registrant&#8217;s telephone number, including area code: <span style="font-family: 'Times New Roman'; font-weight: bold;">(<ix:nonNumeric name="dei:CityAreaCode" id="Fact_dc777792a90f498194395837f882199f" contextRef="c20240530to20240530">980</ix:nonNumeric>)<span style="font-weight: bold;">-</span></span><span style="font-weight: bold;"><ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_a407cae3a6924a90ae700a7b53c44ad6" contextRef="c20240530to20240530">221-3235</ix:nonNumeric></span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Not Applicable</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt;">(Former name or former address, if changed since last report)</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_302e5b08350f4f319889691605e3261a" contextRef="c20240530to20240530" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_e43be113d2c4468c8bf3f69e2faa34c0" contextRef="c20240530to20240530" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_d097f2c46a0b472b8f7285fc4415d6e3" contextRef="c20240530to20240530" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 27pt; vertical-align: top; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_dc3d0b9229d94fdba478bff6297efa18" contextRef="c20240530to20240530" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric><br/>
          </td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman';">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40.8%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;">Title of Each Class</span></div>
          </td>

    <td style="width: 15.52%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;">Trading Symbol(s)</span></div>
          </td>

    <td style="width: 43%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><span style="text-decoration: underline;">Name of Each Exchange on Which Registered</span></div>
          </td>

  </tr>

  <tr>

    <td style="width: 40.8%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_8288a8a92a6e434da7b97b9f52bbd80a" contextRef="c20240530to20240530">Common Stock, par value $0.10 per share</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 15.52%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_864db98ed23047c98f532b3b636ec99c" contextRef="c20240530to20240530">SEE</ix:nonNumeric><br/>
            </div>
          </td>

    <td style="width: 43%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: center; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6042107e52de4d3bba58cf8f39601261" contextRef="c20240530to20240530" format="ixt-sec:exchnameen">New York Stock Exchange</ix:nonNumeric></div>
          </td>

  </tr>


</table>
    <div><br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 under the Securities Act of 1933 <span style="font-family: 'Times New Roman';">(&#167;230.405 of this chapter)</span> or Rule 12b-2 of the Securities Act of 1934 (<span style="font-family: 'Times New Roman';">&#167;240.12b-2 of this chapter</span>).</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Emerging growth company&#160; <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_94d58b96781a48358132766b144e275a" contextRef="c20240530to20240530" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
      financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; &#9744;</div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;"> <br/>
    </div>

    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;"/> </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 5.02</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Departure of Officer</span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;"><span style="font-size: 10pt; font-family: 'Times New Roman';">On May 30, 2024, Sealed Air Corporation (the &#8220;Company&#8221;) and Tobias Grasso, Jr., President,
        Americas of the Company, mutually agreed that Mr. Grasso will be stepping down from his current position as an executive officer effective June 4, 2024, and continue to serve in an advisory role through July 1, 2024.</span><span style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">&#160; </span><span style="font-size: 10pt; font-family: 'Times New Roman';">There are no changes to the severance that Mr. Grasso is entitled to receive pursuant to the Sealed Air Corporation
        Executive Severance Plan (the &#8220;Plan&#8221;).</span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;"><span style="text-decoration: underline;">Amendment and Restatement of Executive Severance Plan</span></div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">On June 1, 2024, the People and Compensation Committee of the Board of Directors of the Company approved an amendment and restatement of the Plan to include
      CEO severance arrangements as follows:</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event of a termination without cause or by the CEO for good reason not in connection with a change in control, the CEO will receive:</div>
            </div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">cash severance in an amount equal to two (2) times the sum of the CEO&#8217;s annual base salary plus target annual bonus, payable in an immediate lump sum;</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">a pro rata bonus for the year in which the involuntary termination occurs based on actual performance results for the year and payable at the same time bonuses for the year are otherwise paid; and</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">a payment equal to 24 times the then applicable employee cost for monthly premiums for medical, prescription and dental benefits under the Company plans based on the CEO&#8217;s then applicable election,
              payable in an immediate lump sum.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 18pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">&#8226;</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">
              <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">In the event of a termination without cause or by the CEO for good reason in connection with a change in control, the CEO will receive</div>
            </div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">cash severance in an amount equal to two and one half (2.5) times the sum of the CEO&#8217;s annual base salary plus target annual bonus, payable in an immediate lump sum;</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">a pro rata bonus for the year in which the involuntary termination occurs, based on the greater of assumed target performance or actual performance measured through the end of the calendar quarter
              preceding the change in control, payable in an immediate lump sum;</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">a payment equal to 24 times the then applicable employee cost for monthly premiums for medical, prescription and dental benefits under the Company plans based on the CEO&#8217;s then applicable election,
              payable in an immediate lump sum; and</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 54pt; font-size: 10pt;"><br/>
          </td>

    <td style="width: 18pt; vertical-align: top; font-family: 'Times New Roman'; font-size: 10pt;">o</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="font-family: 'Times New Roman';">full vesting of all outstanding equity compensation awards, consistent with the terms that apply to other participants in the Plan.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The eligibility for severance for the CEO under the Plan remains subject to all other terms and conditions of the Plan, including the requirements that the
      CEO provide a release of claims and comply with certain post-employment covenants.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">
      <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">No changes were made to the severance benefits for non-CEO participants in the Plan.</div>

    </div>

    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">The foregoing summary of the terms and conditions of the Plan is not a complete discussion of the document. Accordingly, the foregoing is qualified in its
      entirety by reference to the full text of the Plan included as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;" class="DSPFListTable">


  <tr>

    <td style="width: 45pt; vertical-align: top; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Item 9.01</td>

    <td style="width: auto; vertical-align: top; text-align: left; font-size: 10pt;">
            <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Financial Statements and Exhibits.</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman'; font-size: 10pt;">(d)&#160; Exhibits.</div>

    <div style="font-size: 10pt;">&#160;</div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 6%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit</div>
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Number</div>
          </td>

    <td style="width: 3%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">&#160;</td>

    <td style="width: 91%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-weight: bold;">Description</div>
          </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';"><a href="ef20030540_ex10-1.htm">10.1</a></div>
          </td>

    <td style="width: 3%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 91%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; font-family: 'Times New Roman';">Sealed Air Corporation Executive Severance Plan (as amended and restated effective June 1, 2024).</div>
          </td>

  </tr>

  <tr>

    <td style="width: 6%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">104</div>
          </td>

    <td style="width: 3%; vertical-align: bottom; font-size: 10pt;">&#160;</td>

    <td style="width: 91%; vertical-align: bottom; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Cover Page Interactive Data File (formatted as Inline XBRL and embedded within document)</div>
          </td>

  </tr>


</table>
    <div style="font-size: 10pt;"><br/>
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="BRPFPageBreakArea">
      <div style="page-break-after: always;" class="BRPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"/></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SIGNATURE</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <div style="text-align: left; text-indent: 40.5pt; font-family: 'Times New Roman'; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the
      undersigned, hereunto duly authorized.</div>

    <div style="text-align: center;"><span style="font-size: 10pt; font-family: 'Times New Roman';"> </span><span style="font-size: 10pt;"><br/>
      </span></div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td colspan="2" style="vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">SEALED AIR CORPORATION</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">By:</div>
          </td>

    <td style="width: 45%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">/s/ Angel S. Willis</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Name:</div>
          </td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Angel S. Willis</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Title:</div>
          </td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Vice President, General Counsel and Secretary</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">(Duly Authorized Officer)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top; font-size: 10pt;">
            <div style="text-align: left; color: rgb(0, 0, 0); font-family: 'Times New Roman';">Date: June 4, 2024</div>
          </td>

    <td style="width: 5%; vertical-align: top; font-size: 10pt;">&#160;</td>

    <td style="width: 45%; vertical-align: top; font-size: 10pt;">&#160;</td>

  </tr>


</table>
    <div style="font-size: 10pt;">&#160;</div>

    <div style="font-size: 10pt;"> <br/>
    </div>

    <div style="font-size: 10pt;">
      <hr style="height: 2px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;"/> </div>

  </div>

  <div><span style="font-size: 10pt;"> </span></div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ef20030540_ex10-1.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc
         Document created using Broadridge PROfile 24.3.1.5224
         Copyright 1995 - 2024 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <!--PROfilePageNumberReset%Num%1%%%-->
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Exhibit 10.1</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">SEALED AIR CORPORATION EXECUTIVE SEVERANCE PLAN</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">(as amended and restated effective June 1, 2024)</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 1</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Purpose</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">Sealed Air Corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Plan Sponsor</font>&#8221;), on behalf of each
      participating entity included as the Company, hereby adopts the Sealed Air Corporation Executive Severance Plan (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Plan</font>&#8221;), effective as of the Effective Date.
      The Plan is established to provide financial assistance to a Participant whose Employment is terminated due to an Involuntary Termination of Employment occurring on or after the Effective Date. This document is an amendment and restatement of the
      Plan effective as of June 1, 2024 to reflect a change in design on the calculation of severance benefits. The design changes in this amendment and restatement apply only to an Involuntary Termination of Employment that occurs after such date.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Plan, as a &#8220;severance pay arrangement&#8221; within the meaning of Section 3(2)(B)(i) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">ERISA</font>&#8221;), is intended to meet all applicable requirements of ERISA and regulations thereunder, as in effect from time to time. The Plan is intended to be and shall be
      administered and maintained as an unfunded &#8220;welfare plan&#8221; under Section 3(1) of ERISA, and is intended to be exempt from the reporting and disclosure requirements of ERISA as an unfunded welfare plan for a select group of management or highly
      compensated employees.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The establishment of the Plan shall not affect or modify the rights of a Participant with respect to severance benefits under any individual employment
      agreement or change in control agreement with a Participant (exclusive of termination treatment provisions in equity awards) (each, an &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Agreement</font>&#8221;). In no event
      may a Participant receive severance benefits under both this Plan and an Agreement, or any other arrangement with the Company, except to the extent the Company expressly determines otherwise. If a Participant has an Agreement and such Agreement
      provides for the payment of severance benefits in connection with a Participant&#8217;s Involuntary Termination of Employment, to the extent the events giving rise to the Involuntary Termination of Employment are covered by such Agreement, such Agreement
      and not this Plan shall govern the payment of severance benefits relating to such Involuntary Termination of Employment. In addition, the establishment of this Plan does not nullify or replace any non-competition, release of claims or other
      agreements between the Company and any of its employees or former employees entered into in connection with any such Agreements.</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 2</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Definitions</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Affiliate</u></font>. All members of any controlled group within the meaning of Code Sections 414(b) and (c) that includes the Plan Sponsor.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Base Salary</u></font>. A Participant&#8217;s annualized base pay at the rate in effect immediately before his or her Separation Date, and in all cases excluding bonuses, commissions, overtime or any other form of variable or extra
        compensation.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Board</u></font>. The Board of Directors of the Plan Sponsor.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cause</u></font>. Any conduct of a Participant contained in the following list:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Participant engaging in fraud, embezzlement, or
        theft in connection with the Participant&#8217;s duties or in the course of his or her employment;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">an act or omission by the Participant that is willfully
        or grossly negligent, contrary to the Company&#8217;s established policies or practices, or materially harmful to the Company&#8217;s business or reputation or to the business of the Company&#8217;s customers or suppliers as it relates to the Company;</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Participant&#8217;s plea of no contest to, or conviction
        of, a felony;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Participant&#8217;s substantial failure to perform his or
        her duties after receiving notice of the failure from the Plan Administrator, which failure has not been cured within thirty (30) days after the Participant receives notice of the failure; or</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">the Participant&#8217;s breach of a restrictive covenant under
        Section 4.6.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Change in Control</u></font>. The occurrence of any of the following events:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any person becomes the beneficial owner (within the
        meaning of Rule 13d-3 promulgated under the Securities Exchange Act of 1934) of 30% or more of the outstanding voting securities of the Plan Sponsor entitled to vote generally in the election of directors (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Outstanding Voting Securities</font>&#8221;); <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that, for purposes of this definition, the following acquisitions shall not constitute a Change in Control: (i) any acquisition directly from the Plan Sponsor, (ii) any acquisition by the Plan
        Sponsor, (iii) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Plan Sponsor, or (iv) any acquisition pursuant to a reorganization, merger, statutory share exchange, consolidation, sale of all or
        substantially all of the Plan Sponsor&#8217;s assets, or the acquisition of assets or stock of another entity by the Plan Sponsor, or other corporate transaction involving the Plan Sponsor or any of its subsidiaries (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Corporate Transaction</font>&#8221;) that complies with subsections (b), (c) and (d) of this definition;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Continuing Directors cease for any reason to constitute
        at least a majority of the Board;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Consummation of a Corporate Transaction unless,
        following such Corporate Transaction, (i) all or substantially all of the individuals and entities that were the beneficial owners of the Outstanding Voting Securities immediately prior to such Corporate Transaction beneficially own, directly or
        indirectly, more than 50% of the then-outstanding combined voting power of the then-outstanding voting securities entitled to vote generally in the election of directors (or, for a non-corporate entity, equivalent governing body) of the entity
        resulting from such Corporate Transaction (including, without limitation, an entity that, as a result of such transaction, owns the Plan Sponsor or all or substantially all of the Plan Sponsor&#8217;s assets either directly or through one or more
        subsidiaries) in substantially the same proportions as their ownership of the Outstanding Voting Securities immediately prior to such Corporate Transaction, (ii) no person (excluding any corporation resulting from such Corporate Transaction or any
        employee benefit plan (or related trust) of the Plan Sponsor or such corporation resulting from such Corporate Transaction) beneficially owns, directly or indirectly, 30% or more of the combined voting power of the then-outstanding voting
        securities of such entity, except to the extent that such ownership existed prior to the Corporate Transaction, and (iii) at least a majority of the members of the board of directors (or, for a non-corporate entity, equivalent governing body) of
        the entity resulting from such Corporate Transaction were Continuing Directors at the time of the execution of the initial agreement or of the action of the Board providing for such Corporate Transaction; or</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The stockholders of the Plan Sponsor give approval of a
        complete liquidation or dissolution of the Plan Sponsor.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">Notwithstanding the foregoing, if it is determined that any amounts payable hereunder are subject to the requirements of Section 409A of the Code and payable upon a Change
      in Control, the Plan Sponsor will not be deemed to have undergone a Change in Control unless the Plan Sponsor is deemed to have undergone a &#8220;change in control event&#8221; pursuant to the definition of such term in Section 409A of the Code.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>COBRA</u></font>. The Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Code</u></font>. The Internal Revenue Code of 1986, as amended from time to time (including any valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder).</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Company</u></font>. The Plan Sponsor, its successor and assigns, and any of its United States Affiliates that, with the consent of the Plan Sponsor, adopt the Plan for the benefit of their employees. The Plan Sponsor may act on behalf
        of any such adopting Affiliate for purposes of this Plan.</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Continuing Director</u></font>. A director of the Plan Sponsor who is serving as such on the Effective Date and any person who is approved as a nominee or elected to the Board by a majority of the Continuing Directors who are then
        members of the Board, but excluding, for this purpose, any such person whose initial assumption of office occurs as a result of an actual or threatened election contest with respect to the election or removal of directors or other actual or
        threatened solicitation of proxies or consent by or on behalf of a person other than the Board.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.10</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disabled or Disability</u></font>. An incapacity that has resulted in qualification of a Participant to receive long-term disability benefits under The Sealed Air Long Term Disability Insurance Plan. If the Participant is not covered
        by The Sealed Air Long Term Disability Insurance Plan, the Participant is considered to have a Disability if the Participant&#8217;s incapacity results in a determination by the Social Security Administration that the Participant is entitled to a Social
        Security disability benefit. The Plan Administrator may establish uniform and nondiscriminatory time limits for such determination by the Social Security Administration and for notice of such determination to be provided to the Plan Administrator
        in order for such incapacity to be a Disability under the Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.11</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Effective Date</u></font>. February 5, 2014.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.12</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Employment</u></font>. A Participant&#8217;s employment with the Company, beginning on the Participant&#8217;s original date of hire and ending on the Participant&#8217;s Separation Date. To the extent required by any applicable purchase agreement or
        as otherwise determined by the Plan Sponsor, a Participant&#8217;s period of Employment also includes, if applicable, time with any entity prior to the entity being acquired by or merging with the Company.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.13</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Good Reason</u></font>. &#8220;Good Reason&#8221; as defined under a Participant&#8217;s employment agreement with the Company, in the event one exists, or otherwise a Participant&#8217;s termination of Employment following the initial existence of one or
        more of the following conditions without the consent of the Participant:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a material diminution in the Participant&#8217;s base
        compensation;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a material diminution in the Participant&#8217;s authority,
        duties, or responsibilities; or</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">a material change in the geographic location at which
        the Participant must perform the services; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that
        a relocation of less than fifty (50) miles from the Participant&#8217;s then present location will not be considered a material change in geographic location.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">For a termination of Employment to constitute a termination for Good Reason, the Participant must provide notice to the Company of the existence of the condition described
      above within thirty (30) days of the initial existence of the condition, upon the notice of which the Company has thirty (30) days to remedy the condition. If the condition is not remedied by the Company within thirty (30) days of the notice, the
      Participant must terminate his or her employment within thirty (30) days after the failure to remedy the condition.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.14</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Involuntary Termination of Employment</u></font>. A Participant&#8217;s termination of Employment, other than by reason of death or Disability, (a) by the Company without Cause, or (b) by the Participant for Good Reason.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.15</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Participant</u></font>. Any individual selected by the Plan Administrator to participate in the Plan pursuant to Article 3.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.16</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Plan</u></font>. The Sealed Air Corporation Executive Severance Plan, as stated herein and as may be amended from time to time.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.17</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Plan Administrator</u></font>. The People and Compensation Committee of the Board or any committee or other person or persons designated by the Board to administer the Plan pursuant to Section 5.2, which shall control and manage the
        operation and administrative of the Plan as the named fiduciary.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.18</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Plan Year</u></font>. The calendar year. The first Plan Year shall begin on the Effective Date and end on December 31, 2014.</font></div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.19</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Separation Date</u></font>. A Participant&#8217;s last day of active Employment (i.e., the last day the Participant works for the Company) due to an Involuntary Termination of Employment which entitles the Participant to benefits from the
        Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.20</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severance Benefits</u></font>. Benefits paid to a Participant pursuant to Article 4.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.21</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Total Cash Compensation</u></font>. The sum of a Participant&#8217;s (a) Base Salary and (b) target annual cash incentive award for the Company&#8217;s fiscal year in which the Separation Date occurs (determined without regard to any Stock
        Leverage Opportunity election by the Participant).</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.22</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Welfare Benefits</u></font>. The basic life insurance, accidental death and dismemberment insurance, long- and short-term disability insurance, and medical, dental, and vision insurance benefits provided by the Company to a given
        Participant (and any eligible dependents).</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.23</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; <font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Year of Service</u></font>. A Participant&#8217;s aggregate period of Employment divided into whole years, subject to the following rules:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any absence of Employment for a period of 12 or more
        successive months shall be excluded;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any remaining partial period of Employment of at least
        six months shall be rounded up to be considered as a full Year of Service;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Any remaining partial period of Employment of less than
        six months shall not be included when calculating Years of Service;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Years of Service of any Participant who previously
        was eligible for severance benefits under the Plan or any other plan, program, policy or arrangement sponsored by the Company and is subsequently rehired by the Company shall be canceled in an amount determined by the Company as appropriate to
        avoid the duplication of the payment of Severance Benefits related to the period of Employment prior to rehire for which severance benefits were earlier paid.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 3</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Eligibility for Benefits Guidelines</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Participation Requirements</u></font>. The Plan Administrator may designate, in its sole discretion and from time to time, one or more employees of the Company to participate in the Plan as Participants.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Notice of Participation</u></font>. The Plan Administrator shall provide each Participant selected to participate in the Plan with a letter notifying the Participant of his or her participation in the Plan and the potential Severance
        Benefits payable under the Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Eligibility for Severance Benefits</u></font>. Under these guidelines, a Participant shall be eligible for Severance Benefits, as determined pursuant to Article 4, if the Participant meets all of the following conditions:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">incurs an Involuntary Termination of Employment;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">executes and returns to the Plan Administrator a general
        written release and waiver of claims, in such form as determined by the Plan Administrator from time to time, within 21 days (or, to the extent required by applicable law, 45 days) after the Participant&#8217;s Separation Date and does not revoke such
        waiver of claims within 7 days after its execution;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">is in compliance with the covenants set forth in Section
        4.6 on the Separation Date;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">returns to the Company any property of the Company that
        has come into the Participant&#8217;s possession; and</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">performs all transition and other matters required of
        the Participant by the Company following his or her Involuntary Termination of Employment.</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Ineligibility for Benefits</u></font>. Under these guidelines, a Participant shall not be eligible to receive Severance Benefits pursuant to Article 4 in the event of any of the following:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Participant&#8217;s termination of Employment for any
        reason other an Involuntary Termination of Employment (for example, termination of Employment by the Company for Cause, by the Participant without Good Reason, or due to the Participant&#8217;s death or Disability); or</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The amendment or termination of the Plan to eliminate a
        Participant&#8217;s eligibility to receive Severance Benefits prior to his or her Separation Date, in accordance with Section 6.1.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 4</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Severance Benefits Guidelines</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severance Benefits</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Involuntary Termination of Employment Not in Connection with a Change in Control</u></font>. Except as otherwise provided on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit A</u></font> to the Plan
        (regarding severance benefits for the Chief Executive Officer of the Plan Sponsor, if a Participant), upon a Participant&#8217;s Involuntary Termination of Employment not occurring upon or within two years following a Change in Control, the Participant
        shall be entitled to receive:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) cash severance equal to one year of Total Cash Compensation, payable in installments over twelve months following the Separation
      Date in accordance with Section 4.2(a); and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) for a period ending upon the earlier of (x) twelve months following the Separation Date and (y) the date on which the Participant
      becomes entitled to comparable Welfare Benefits from another employer:</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) subject to the Participant&#8217;s proper election to continue healthcare coverage under COBRA, payment by the Company of the
      Participant&#8217;s COBRA premiums, less the amount that the Participant would be required to contribute for such healthcare coverage if the Participant were an active employee;</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) continued coverage under the Company&#8217;s other Welfare Benefit plans, to the extent that such continued coverage is permitted by the
      terms of the applicable plan (including any related insurance contract) and applicable law; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(C) with respect to any Welfare Benefits that cannot be provided under subsection (B) pursuant to the terms of the applicable plan
      (including any related insurance contract) or applicable law, cash payments equal to the aggregate premiums that the Company would have paid for the Participant for such Welfare Benefits during the period.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Involuntary Termination of Employment in Connection with a Change in Control</u></font>. Except as otherwise provided on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit A</u></font> to the Plan (regarding
        severance benefits for the Chief Executive Officer of the Plan Sponsor, if a Participant), upon a Participant&#8217;s Involuntary Termination of Employment occurring upon or within two years following a Change in Control, the Participant shall be
        entitled to receive:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) an amount equal to two years of Total Cash Compensation;</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) for a period ending upon the earlier of (x) 18 months following the Separation Date and (y) the date on which the Participant
      becomes entitled to comparable Welfare Benefits from another employer:</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(A) subject to the Participant&#8217;s proper election to continue healthcare coverage under COBRA, payment by the Company of the
      Participant&#8217;s COBRA premiums, less the amount that the Participant would be required to contribute for such healthcare coverage if the Participant were an active employee;</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(B) continued coverage under the Company&#8217;s other Welfare Benefit plans, to the extent that such continued coverage is permitted by the
      terms of the applicable plan (including any related insurance contract) and applicable law; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;">(C) with respect to any Welfare Benefits that cannot be provided under subsection (B) pursuant to the terms of the applicable plan
      (including any related insurance contract) or applicable law, cash payments equal to the aggregate premiums that the Company would have paid for the Participant for such Welfare Benefits during the period; and</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 72pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(iii) full vesting of all outstanding equity compensation awards. In that regard, for any unvested performance-based award, the target
      payout opportunities attainable under such award shall be deemed to have been fully earned as of the Separation Date based upon the greater of: (A) an assumed achievement of all relevant performance goals at the &#8220;target&#8221; level, or (B) the actual
      level of achievement of all relevant performance goals against target as of the Company&#8217;s fiscal quarter end preceding the Change in Control. The post-employment exercise period of any outstanding stock option or similar award shall be as provided
      under the applicable award agreement. The provisions of this Section 4.1(b)(iii) shall apply only to the extent more favorable to the Participant than under the applicable award agreement and only to the extent permitted by the applicable stock plan.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Commencement of Severance Benefits</u></font>.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Severance Benefits payable to a Participant under
        Section 4.1(a) shall be paid out in installments in accordance with the Company&#8217;s payroll practices over the applicable payment periods described in Section 4.1(a)(i) and (a)(ii)(C), beginning on the first regularly scheduled payroll date occurring
        on or after the 60th day following the Separation Date (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">First Payroll Date</font>&#8221;), and any amounts that would otherwise have been paid prior to the First
        Payroll Date shall be paid on the First Payroll Date. Solely for purposes of Section 409A of the Code, each installment payment is considered a separate payment.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The Severance Benefits payable to a Participant under
        Section 4.1(b)(i) and (b)(ii)(C) shall be paid out in a lump sum cash payment on the first regularly scheduled payroll date occurring on or after the 60th day following the Separation Date.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Payment of Severance Benefits Upon Death of Participant</u></font>. If a Participant dies after Severance Benefits become payable under the Plan but prior to the date payment of Severance Benefits is completed, the actuarial
        equivalent present value of the Severance Benefits remaining to be paid, as determined solely by the Plan Administrator, shall be paid in a single lump sum no later than March 15 following the calendar year in which the Participant&#8217;s death occurs
        to the Participant&#8217;s legal surviving spouse, or if none, to the Participant&#8217;s estate. Notwithstanding any provision of the Plan to the contrary, no Severance Benefits shall be paid following the death of the Participant unless the Company receives
        any release, agreement, waiver or other document required to be provided by the Participant&#8217;s surviving spouse or estate, as applicable, as a condition of receipt of Severance Benefits within the time frame required under the applicable release,
        agreement, waiver or other document but no later than 60 days following the Participant&#8217;s death, to the extent required by the Plan Administrator.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cessation of Benefits</u></font>. Payment of Severance Benefits under the Plan shall cease immediately:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Upon discovery by the Company that the Participant,
        while working as an employee of the Company, engaged in any activity which would have constituted Cause; or</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">Upon discovery by the Company that the Participant has
        violated confidentiality, non-competition, non-solicitation or other covenants to which the Participant may be subject under Section 4.6.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Repayment of Benefits</u></font>. The Company reserves the right to recover Severance Benefits in the event a Participant violates any covenant to which he or she is subject under Section 4.6 or commits an action or conduct that
        constitutes Cause.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>. To be eligible to receive Severance Benefits, a Participant must enter into standard Company agreements regarding protection of confidential information and ownership of trade secrets and inventions.
        In addition to any covenants set forth in such standard Company agreements, in consideration for participation in the Plan, the covenants set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font> shall
        apply to each Participant, even if more restrictive than the covenants contained in such standard Company agreements. In order to participate in the Plan, the Company may require a Participant to acknowledge in writing that he or she is subject to
        the restrictive covenants set forth on <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Exhibit B</u></font>.</font></div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 5</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Plan Administration</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Plan Administrator&#8217;s Authority</u></font>. The Plan Administrator shall have full and complete authority to enforce the Plan in accordance with its terms and shall have all powers necessary to accomplish that purpose, including, but
        not limited to, the following:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To apply and interpret the Plan in its absolute
        discretion, including the authority to construe disputed provisions;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To determine all questions arising in its
        administration, including those related to the eligibility of persons to become Participants and eligibility for Severance Benefits, and the rights of Participants;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To compute and certify the amount of Severance Benefits
        payable to Participants;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To authorize all disbursements in accordance with the
        provisions of the Plan;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To employ and reasonably compensate accountants,
        attorneys and other persons to render advice or perform services for the Plan as it deems necessary;</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To make available to Participants upon request, for
        examination during business hours, such records as pertain exclusively to the examining Participant; and</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To appoint an agent for service of legal process.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; font-family: 'Times New Roman'; font-size: 10pt;">All decisions of the Plan Administrator based on the Plan and documents presented to it shall be final and binding upon all persons.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Appointment of Separate Administrator</u></font>. The Plan Sponsor may appoint a separate Plan Administrator which shall be an officer of the Plan Sponsor or a committee consisting of at least two persons. Members of any such
        committee may resign by written notice to the Plan Sponsor and the Plan Sponsor may appoint or remove members of the committee. A Plan Administrator consisting of more than one person shall act by a majority of its members at the time in office and
        may authorize any one or more of its members to execute any document or documents on behalf of the Plan Administrator.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Claims for Benefits</u></font>. Generally, an obligation of the Plan to provide Severance Benefits to a Participant arises only when a written offer of Severance Benefits has been communicated by the Plan Administrator to the
        Participant. A Participant not receiving Severance Benefits who believes that he is eligible for such benefits, or a Participant disputing the amount of Severance Benefits, or any such Participant&#8217;s or Participant&#8217;s authorized representative (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Claimant</font>&#8221;) may request in writing that his claim be reviewed by the Plan Administrator. All such claims for benefits must be submitted to the Plan Administrator at
        the address of the Plan Sponsor&#8217;s corporate headquarters within 60 days after the Participant&#8217;s termination of employment. The review of all claims for benefits shall be governed by the following rules:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Time Limits on Decision</u></font>. Unless special circumstances exist, a Claimant who has filed a claim shall be informed of the decision on the claim within 90 days of the Plan Administrator&#8217;s receipt of the written claim. This
        period may be extended by an additional 90 days if special circumstances require an extension of time, provided the Participant is notified of the extension within the initial 90-day period. The extension notice shall indicate:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) The special circumstances requiring the extension of time; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) The date, no later than 180 days after receipt of the written claim, by which the Claimant can expect to receive a decision.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Content of Denial Notice</u></font>. If a claim for benefits is partially or wholly denied, the Claimant will receive a written notice that:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) States the specific reason or reasons for the denial;</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) Refers to the specific Plan provisions on which the denial is based;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">7</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(iii) Describes and explains the need for any additional material or information that the Claimant must supply in order to perfect the
      claim; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(iv) Describes the Plan&#8217;s review procedures and the time limits applicable to such procedures, including a statement of the Claimant&#8217;s
      right to bring a civil action under Section 502(a) of ERISA following an adverse benefit determination on review.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;5.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Appeal of Denied Claims</u></font>. If the Claimant&#8217;s claim is denied and he or she wants to submit a request for a review of the denied claim, the following rules apply:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Review of Denied Claim</u></font>. If a Claimant wants his or her denied claim to be reconsidered, the Claimant must send a written request for a review of the claim denial to the Plan Administrator no later than 60 days after the
        date on which he or she receives written notification of the denial. The Claimant may include any written comments, documents, records or other information relating to the claim for benefits. The Claimant shall be provided, upon request and free of
        charge, reasonable access to, and copies of, all documents, records and other information relating to the claim for benefits. The Plan Administrator&#8217;s review shall take into account all comments, documents, records and other information submitted
        by the Claimant relating to the claim, without regard to whether such information was submitted or considered in the initial benefit determination.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Decision on Review</u></font>. The Plan Administrator shall review the denied claim and provide a written decision within 60 days of the date the Plan Administrator receives the Claimant&#8217;s written request for review. This period may
        be extended by an additional 60 days if special circumstances require an extension of time, provided the Participant is notified of the extension within the initial 60-day period. The extension notice shall indicate:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) The special circumstances requiring the extension of time; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) The date, no later than 120 days after receipt of the written request for review, by which the Claimant can expect to receive a
      decision.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">&#160;(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Content of Denial Notice</u></font>. If a claim for benefits is partially or wholly denied on appeal, the Claimant will receive a written notice that:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(i) States the specific reason or reasons for denial;</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(ii) Refers to the specific Plan provisions on which the denial is based;</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(iii) Includes a statement that the Claimant is entitled to receive, upon request and free of charge, reasonable access to, and copies
      of, all documents, records and other information relevant to the claim; and</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(iv) Includes a statement of the right to bring a civil action under Section 502(a) of ERISA.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Limitations on Legal Actions; Dispute Resolution</u></font>. Claimants must follow the claims procedures described in this Article 5 before taking action in any other forum regarding a claim for benefits under the Plan. Furthermore,
        any such action initiated by a Claimant under the Plan must be brought by the Claimant within one year of a final determination on the claim for benefits under these claims procedures, or the Claimant&#8217;s benefit claim will be deemed permanently
        waived and abandoned, and the Claimant will be precluded from reasserting it. Further, after following the claims procedures described in this Article 5, except with respect to enforcement of any covenants in connection with Section 4.6, the
        following provisions apply to any further disputes that may arise regarding this Plan:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">In the event of any dispute, claim, question or
        disagreement arising out of or relating to this Plan, the parties shall use their best efforts to settle such dispute, claim, question or disagreement. To this effect, they shall consult and negotiate with each other, in good faith, and,
        recognizing their mutual interests, attempt to reach a just and equitable resolution satisfactory to both parties.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">If the parties do not reach such a resolution within a
        period of 30 days, then any such unresolved dispute or claim, upon notice by any party to the other, shall be submitted to and finally settled by arbitration in accordance with the Commercial Arbitration Rules (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Rules</font>&#8221;) of the AAA in effect at the time demand for arbitration is made by any such party. The parties shall mutually agree upon a single arbitrator within 30 days of such demand. In the
        event that the parties are unable to so agree within such 30 day period, then within the following 30 day period, one arbitrator shall be named by each party. A third arbitrator shall be named by the two arbitrators so chosen within ten 10 days
        after the appointment of the first two arbitrators. In the event that the third arbitrator is not agreed upon, he or she shall be named by the AAA. Arbitration shall occur in the State of North Carolina or such other location as may be mutually
        agreed to by the parties.</font></div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">8</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">The award made by all or a majority of the panel of
        arbitrators shall be final and binding, and judgment may be entered based upon such award in any court of law having competent jurisdiction. The award is subject to confirmation, modification, correction or vacation only as explicitly provided in
        Title 9 of the United States Code. The parties acknowledge that this Plan evidences a transaction involving interstate commerce. The United States Arbitration Act and the Rules shall govern the interpretation, enforcement, and proceedings pursuant
        to this Section 5.5. Any provisional remedy which would be available from a court of law shall be available from the arbitrators to the parties to this Plan pending arbitration. Either party may make an application to the arbitrators seeking
        injunctive relief to maintain the status quo, or may seek from a court of competent jurisdiction any interim or provisional relief that may be necessary to protect the rights and property of that party, until such times as the arbitration award is
        rendered or the controversy otherwise resolved.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">To the full extent permitted by law and upon
        presentation of appropriate documentation, all reasonable legal fees and expenses incurred by a Participant as a result of any dispute under this Section 5.5 involving the validity or enforceability of, or liability under, any provision of this
        Plan (including as a result of any dispute involving the amount of any payment or other benefit due pursuant to this Plan) shall be paid by the Company if the Company unreasonably or maliciously contested the validity or enforceability of any
        provision of this Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">By agreeing to binding arbitration, a Participant must
        waive his or her right to a jury trial. The claims covered by this Section 5.5 include any statutory claims regarding a Participant&#8217;s Employment or the termination of his or her Employment, including without limitation claims regarding workplace
        discrimination.</font></div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 6</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Plan Amendment and Termination</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Power to Amend and Terminate</u></font>. The Plan Sponsor may at any time terminate or amend the Plan in its sole discretion with respect to any or all Participants and Participants for any reason, including altering, reducing or
        eliminating benefits to be paid to Participants who have not yet experienced a Separation Date; <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">provided</font>, <font style="font-size: 10pt; font-family: 'Times New Roman'; font-style: italic;">however</font>, that any amendment or termination that eliminates potential Severance Benefits for a Participant shall not be effective until one year after notice is provided to the Participant, provided that
        beginning June 1, 2025, such notice must be provided at least ninety (90) days (rather than one year) before such amendment is effective. The provisions of the Plan as in effect at the time of a Participant&#8217;s Separation Date shall control any Plan
        benefits paid to that Participant, unless modified by the Plan Sponsor or otherwise specified in the Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">6.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successor Employer</u></font>. Any successor to all or any portion of the business of the Plan Sponsor may, with the consent of the Plan Sponsor, continue the Plan. Such successor shall succeed to all the rights, powers, and duties of
        the Plan Sponsor. The Employment of any Participant who continues in the employ of the successor shall not be deemed to have been terminated or severed for purposes of this Plan.</font></div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">9</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">ARTICLE 7</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Miscellaneous Provisions</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.1</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 280G</u></font>. Notwithstanding any other provision of this Plan or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company or its Affiliates to a
        Participant or for a Participant&#8217;s benefit pursuant to the terms of this Plan or otherwise (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Covered Payments</font>&#8221;) constitute &#8220;parachute payments&#8221; within the
        meaning of Section 280G of the Code and would, but for this Section 7.1 be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or
        penalties with respect to such taxes (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Excise Tax</font>&#8221;), then the Covered Payments shall be payable either (i) in full or (ii) reduced to the
        minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax, whichever of the foregoing (i) or (ii) results in the Participant&#8217;s receipt on an after-tax basis of the greatest amount of benefits after
        taking into account the applicable federal, state, local and foreign income, employment and excise taxes (including the Excise Tax). Any determination required under this Section 7.1 shall be made by the Company in its sole discretion.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.2</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Section 409A</u></font>. It is intended that the payments and benefits set forth in Article 4 are, to the greatest extent possible, exempt from the application of Code Section 409A and the Plan shall be construed and interpreted
        accordingly. However, if the Company (or, if applicable, the successor entity thereto) determines that all or a portion of the payments and benefits provided under the Plan constitute &#8220;deferred compensation&#8221; under Section 409A and that the
        Participant is a &#8220;specified employee&#8221; of the Company or any successor entity thereto, as such term is defined in Section 409A(a)(2)(B)(i), then, solely to the extent necessary to avoid the incurrence of the adverse personal tax consequences under
        Section 409A, the timing of the applicable payments shall be delayed until the first payroll date following the six-month anniversary of the Participant&#8217;s &#8220;separation from service&#8221; (as defined under Section 409A) and the Company (or the successor
        entity thereto, as applicable) shall (A) pay to the Participant a lump sum amount equal to the sum of the payments that the Participant would otherwise have received during such six-month period had no such delay been imposed and (B) commence
        paying the balance of the payments in accordance with the applicable payment schedule set forth in the Plan. For purposes of Section 409A, each installment payment provided under the Plan shall be treated as a separate payment. To the extent
        required by Section 409A, any payments to be made to a Participant upon his termination of employment shall only be made upon such Participant&#8217;s separation from service. The Company makes no representations that the payments and benefits provided
        under the Plan comply with Section 409A and in no event shall the Company be liable for all or any portion of any taxes, penalties, interest or other expenses that may be incurred by the Participant on account of noncompliance with Section 409A.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.3</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Limitation on Liability</u></font>. In no event shall the Company, the Plan Administrator or any officer or director of the Company incur any liability for any act or failure to act with respect to the Plan.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.4</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Assignment of Benefits</u></font>. Benefits paid under the Plan are for the sole use of Plan Participants. Except as required by law, benefits provided under the Plan cannot be assigned, transferred or pledged to anyone as
        collateral for a debt or other obligation.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.5</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Construction</u></font>. Words used in the masculine gender shall include the feminine and words used in the singular shall include the plural, as appropriate.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.6</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conflict with Applicable Law</u></font>. If any provisions of ERISA or other applicable law render any provision of this Plan unenforceable, such provision shall be of no force and effect only to the minimum extent required by such
        law.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.7</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Contract of Employment</u></font>. Nothing contained in this Plan shall be construed to constitute a contract of employment between the Company and any employee or impose on the Company an obligation to retain any Participant as an
        employee, to continue any Participant&#8217;s current employment status or to change any employment policies of the Company, nor shall any provision hereof restrict the right of the Company to discharge any of its employees or restrict the right of any
        such employee to terminate his or her employment with the Company.</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">10</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.8</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Source of Benefits</u></font>. The Plan is intended to be an unfunded welfare benefit plan for purposes of ERISA and a severance pay arrangement within the meaning of Section 3(2)(B)(i) of ERISA. All benefits payable pursuant to the
        Plan shall be paid or provided by the Company from its general assets. The Plan is not intended to be a pension plan described in Section 3(2)(A) of ERISA.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.9</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Withholding</u></font>. The Company shall have the authority to withhold or cause to have withheld applicable income and payroll taxes from any payments made under the Plan to the extent required by law.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">7.10</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law</u></font>. The Plan will be construed and enforced according to the laws of the State of North Carolina (other than its laws respecting choice of law) to the extent, if any, not preempted by ERISA.</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">11</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%A-%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT A</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Special Provisions for CEO</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">1.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>General</u></font>.&#160; This Exhibit A applies to the CEO, if the CEO is designated as a Participant in the Plan in accordance with Section 3.1 of the Plan.&#160; Except as otherwise expressly provided by this Exhibit A, the terms and
        conditions of the Plan shall apply to the CEO in the same manner as any other Participant.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">2.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-CIC Severance Benefits</u></font>.&#160; Notwithstanding the provisions of Section 4.1(a) of the Plan to the contrary, upon the CEO&#8217;s Involuntary Termination of Employment not occurring upon or within two years following a Change in
        Control, the CEO shall be entitled to receive:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cash Severance</u></font>. The CEO shall receive cash severance in an amount equal to two (2) times the CEO&#8217;s Total Cash Compensation.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pro Rata Bonus</u></font>.<font style="font-size: 12pt; font-family: 'Times New Roman';">&#160;</font>The CEO shall receive a Pro Rata Bonus for the year in which the Involuntary Termination of Employment occurs.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Healthcare Cost Payment</u></font>.&#160; The CEO shall receive a payment equal to (i) twenty-four (24) times (ii) the then-applicable employee cost for monthly premiums for medical, prescription and dental benefits
        under the Company plans based on the CEO&#8217;s then-applicable elections in effect immediately before the Involuntary Termination of Employment.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">3.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>CIC Severance Benefits</u></font>. Notwithstanding the provisions of Section 4.1(b) of the Plan to the contrary, upon the CEO&#8217;s Involuntary Termination of Employment occurring upon or within two years following a Change in Control,
        the CEO shall be entitled to receive:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Cash Severance</u></font>. The CEO shall receive cash severance in an amount equal to an amount equal to two and one-half (2.5) times the CEO&#8217;s Total Cash Compensation.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pro Rata Bonus</u></font>.<font style="font-size: 12pt; font-family: 'Times New Roman';">&#160;</font>The CEO shall receive a Pro Rata Bonus for the year in which the Involuntary Termination of Employment occurs.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Healthcare Cost Payment</u></font>.&#160; The CEO shall receive a payment equal to (i) twenty-four (24) times (ii) the then-applicable employee cost for monthly premiums for medical, prescription and dental benefits
        under the Company plans based on the CEO&#8217;s then-applicable elections in effect immediately before the Involuntary Termination<font style="font-size: 12pt; font-family: 'Times New Roman';">&#160;</font>of Employment.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Equity Vesting</u></font>.&#160; The equity vesting provisions of Section 4.1(b)(iii) of the Plan shall apply.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">4,</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Timing of Payments</u></font>.&#160; The cash severance and healthcare cost payments under Sections 2(a) and 2(c), and the cash severance, Pro Rata Bonus, and healthcare cost payments under Sections 3(a), 3(b), and 3(c), as applicable,
        shall be paid out in a lump sum cash payment on the first regularly scheduled payroll date occurring on or after the 60th day following the Separation Date.&#160; The Pro Rata Bonus under Section 2(b) shall be paid at the same time as generally
        applicable under the Company&#8217;s annual bonus plan, after certification of performance results by the Plan Administrator, and in no event later than March 15 of the following year.</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">5.</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"><font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definitions</u></font>.&#160; For purposes of this Exhibit A, the following terms shall have the following meanings:</font></div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>CEO</u></font>&#8221; means the chief executive officer of the Plan Sponsor.</font></div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';"> <br>
      </font></div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman';">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman';"> &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Pro Rata Bonus</u></font>&#8221; means a pro-rata portion of the annual cash bonus under the applicable Company plan for the year in which an Involuntary Termination occurs equal to a fraction, the numerator of which is the number of
        calendar days during such year through (and including) the date of the Involuntary Termination<font style="font-size: 12pt; font-family: 'Times New Roman';">&#160;</font>of Employment and the denominator of which is 365, with such pro-rata portion
        earned in an amount, (i) in the case of an Involuntary Termination of Employment other than on or within two years after a Change in Control, based on the degree to which the applicable performance financial and operational goals are ultimately
        achieved, as determined by the Plan Administrator on a basis applied uniformly to the CEO as to other senior executives of the Company, and (ii) in the case of an Involuntary Termination of Employment on or within two years after a Change in
        Control, based upon the greater of: (A) an assumed achievement of all relevant performance goals at the &#8220;target&#8221; level, or (B) the actual level of achievement of all relevant performance goals against target as of the Company&#8217;s fiscal quarter end
        preceding the Change in Control.</font></div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">A-2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%1%B-%%-->
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">EXHIBIT B</div>
    <div>&#160;</div>
    <div style="text-align: center; font-family: 'Times New Roman'; font-size: 10pt; font-weight: bold;">Restrictive Covenants</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">For purposes of this Exhibit B, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Parent</font>&#8221; means an entity which
      is a holding company of or holds a controlling interest in the Company; &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Affiliates</font>&#8221; means a subsidiary of the Company or the Parent of the Company or a company
      over which the Company or any holding of the Company has control; and the definition of each of the Company, Parent and Affiliates, includes any of their successors-in-interest.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Company, Parent and the Affiliates are part of the global holdings of Sealed Air Corporation, a publicly traded corporation incorporated under the
      laws of the state of Delaware, U.S.A., the primary purpose of which is to serve as the umbrella entity for the Company. The Company, Parent and the rest of the Affiliates located throughout the world are engaged in the development, research,
      manufacture, distribution and sale of food and beverage, protective, shrink and medical applications packaging; specialty materials; and cleaning, sanitation and hygiene products in the food and beverage, hospitality, healthcare, retail, food
      services or building service contractors sectors.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">1. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Acknowledgements</u></font>. The Participant acknowledges that the Company is
      engaged in the highly competitive business of the development, research, manufacture, distribution, and sale of food and beverage, protective, shrink and medical applications packaging; specialty materials; and cleaning, sanitation and hygiene
      products in the food and beverage, hospitality, healthcare, retail, food services or building service contractors sectors, and that the Participant serves in an executive, managerial, research, or sales capacity, and/or other designated position for
      the Company. Further, the Participant acknowledges that in the course of the Participant&#8217;s employment with the Company, the Participant (i) has been given and will continue to be given access to trade secrets and other Confidential Information (as
      hereinafter defined); (ii) has participated and will continue to participate in the development of, execution of, and/or usage of inventions, products, concepts, strategies, methods, or technologies which are related to the Company&#8217;s business; (iii)
      has been given and will continue to be given specialized training relating to the Company&#8217;s products and/or processes; and/or (iv) has been given and will continue to be given access to the Company&#8217;s customers and other business relationships.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">2. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Disparagement</u></font>. During the Participant&#8217;s employment with the Company
      and thereafter, the Participant will not make or publish any disparaging or derogatory statements about the Company, its products, parent and any of the Affiliates, together with their past, present and future officers, directors, employees,
      attorneys and agents. Disparaging or derogatory statements include, but are not limited to, negative statements regarding the Company&#8217;s business or other practices; provide, nothing herein shall prohibit the Participant from providing any information
      as may be compelled by law or legal process or may be a protected disclosure under statutory law.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">3. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Disclosure of Confidential Information</u></font>. The Participant acknowledges
      that Confidential Information is a valuable, special, and unique asset of the Company, Parent, and the Affiliates, and agrees to the following:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(a) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Confidential Information Defined</u></font>. The term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Confidential Information</font>&#8221; includes but is not limited to, any and all of the Company&#8217;s Parent&#8217;s or Affiliates&#8217; trade secrets, confidential and proprietary information and all other
      information and data of the Company that is not generally known to the public or other third parties who could derive economic value for its use or disclosure. Confidential Information includes, without limitation, the following: (i) marketing,
      sales, and advertising information such as lists of actual or potential customers; customer preference data; marketing and sales techniques, strategies, efforts, and data; merchandising systems and plans; confidential customer information including
      identification of key purchasing personnel, account status, needs and ability to pay; business plans; product development and delivery schedules; market research and forecasts; marketing and advertising plans, techniques, and budgets; overall pricing
      strategies; the specific advertising programs and strategies utilized, and the success or lack of success of those programs and strategies; (ii) organizational information such as personnel and salary data; merger, acquisition and expansion
      information; information concerning methods of operation; divestiture information; and competitive information pertaining to the Company&#8217;s distributors; (iii) financial information such as product costs; supplier information; overhead costs; profit
      margins; banking and financing information; and pricing policy practices; (iv) technical information such as secret processes or machines, research projects, product specifications, compounds, formulas, improvements, discoveries, developments,
      designs, inventions, techniques, new products and training methods; (v) information disclosed to the Participant as part of a training process; and (vi) information of third parties provided to the Participant subject to non-disclosure restrictions
      for use in the Participant&#8217;s business for the Company. Confidential Information also includes any work product created by the Participant in rendering services for the Company.</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-1</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Disclosure of Confidential Information</u></font>. During the Participant&#8217;s
      employment with the Company and thereafter, the Participant will not disclose, transfer, or use (or seek to induce others to disclose, transfer, or use) any Confidential Information for any purpose other than (i) disclosure to authorized employees
      and agents of the Company who are bound to maintain the confidentiality of the Confidential Information; and/or (ii) for authorized purposes during the course of the Participant&#8217;s employment in furtherance of the Company&#8217;s business. the Participant&#8217;s
      non-disclosure obligations shall continue as long as the Confidential Information remains confidential and shall not apply to information that becomes generally known to the public through no fault or action of the Participant or others who were
      under non-disclosure obligations as to such information.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(c) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Protection of Confidential Information</u></font>. The Participant will notify the
      Company in writing of any circumstances which may constitute unauthorized disclosure, loss, transfer, or use of Confidential Information. The Participant will use the Participant&#8217;s best efforts to protect Confidential Information from unauthorized
      disclosure, loss, transfer, or use. The Participant will implement and abide by all procedures adopted by the Company to prevent unauthorized disclosure, loss, transfer, or use of Confidential Information.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">4. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Ownership of Confidential Information and Inventions</u></font>.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(a) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Invention Defined</u></font>. The term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Invention</font>&#8221; includes but is not limited to ideas, programs, processes, systems, machinery, equipment, intellectual property, works of authorship, copyrightable materials, discoveries, and/or improvements
      of which the Participant conceives alone or in conjunction with others during the Participant&#8217;s employment with the Company and/or one (1) year after the Participant&#8217;s employment ends which relate to the Company&#8217;s present or future business. An
      Invention is covered by this Exhibit B regardless of whether (i) the Participant conceived of the Invention in the scope of the Participant&#8217;s employment; or (ii) the Invention is patentable.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Ownership of Confidential Information and Inventions</u></font>. Confidential
      Information and Inventions are solely the property of the Company. The Participant agrees that the Participant does not have any rights, title, or interest in any of the Confidential Information or Inventions. Notwithstanding, the Participant may be
      recognized as the inventor of an Invention without retaining any other rights associated therewith.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(c) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Disclosure and Assignment of Inventions</u></font>. The Participant hereby assigns
      to the Company all right, title and interest the Participant may have in any Inventions that are developed, made, authored, or conceived by the Participant (whether alone or with others) during the Participant&#8217;s employment with the Company or during
      such post-employment period described in Section 4(a) of this Exhibit B. The Participant agrees to: (i) promptly disclose all such Inventions in writing to the Company; (ii) keep complete and accurate records of all such Inventions, which records
      shall be the Company property and shall be retained on the Company premises; and (iii) execute such documents and do such other acts as may be necessary in the opinion of the Company to establish and preserve the Company&#8217;s property rights in all such
      Inventions. The Participant will, whenever requested to do so by the Company during employment by the Company or thereafter, at expense of the Company, render such reasonable assistance and execute and assign patent applications, patents, copyrights,
      copyright registrations and other instruments as the Company shall deem necessary or advisable in order to apply for, obtain and from time to time enforce United States patents or patents in foreign countries covering any such Inventions and to place
      in the Company or its nominees, the sole and exclusive right in and to such Inventions, patent applications, patents and copyrights. This section shall not apply to any Invention for which no equipment, supplies, facility or trade secret information
      of the Company was used and which was developed entirely on the Participant&#8217;s own time, and (1) which does not relate (a) directly to the business of the Company or (b) to the Company&#8217;s actual or demonstrably anticipated research or development, or
      (2) which does not result from any work performed by the Participant for the Company.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">5. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Return of Confidential Information and Company Property</u></font>. Immediately
      upon termination of the Participant&#8217;s employment with the Company, for whatever reason, the Participant shall return to the Company all of the Company&#8217;s property relating to the Company&#8217;s business, including without limitation all of the Company&#8217;s
      property which is in the possession, custody, or control of the Participant such as Confidential Information, documents, hard copy files, copies of documents and electronic information/files.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-2</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">6. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Obligations to Other Entities or Persons</u></font>. The Participant warrants that
      the Participant is not bound by the terms of a confidentiality agreement or any other legal obligations which would either preclude or limit the Participant from disclosing or using any of the Participant&#8217;s ideas, inventions, discoveries or other
      information or otherwise fulfilling the Participant&#8217;s obligations as an employee to the Company and under any applicable employment contract, if any, and also under this Exhibit B. While employed by the Company, the Participant shall not disclose or
      use any confidential information belonging to another entity or other person in the performance of the Participant&#8217;s duties and responsibilities to the Company.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">7. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Conflict of Interest and Duty of Loyalty</u></font>. During the Participant&#8217;s
      employment with the Company, the Participant shall not engage, directly or indirectly, in any activity, employment or business venture, whether or not for remuneration, that (i) is competitive with the Company&#8217;s business; (ii) deprives or potentially
      could deprive the Company of any business opportunity; (ii) conflicts or potentially could conflict with the Company&#8217;s business interests; or (iv) is otherwise detrimental to the Company, including but not limited to preparations to engage in any of
      the foregoing activities.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">8. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Non-Competition Covenants</u></font>. The Company and the Participant acknowledge
      and agree that the following non-competition covenants are reasonable and necessary to protect the legitimate interests of the Company, Parent and Affiliates, including, without limitation, the protection of Confidential Information, Inventions and
      goodwill. The Participant agrees to, and covenants to comply with, each of the following separate and divisible restrictions:</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(a) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Definitions</u></font>.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 40.5pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(1) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Competing Product</font>&#8221; is defined as (a)
      any of the following products, services, processes, solutions, equipment, machinery and services: (i) any food and/or beverage packaging product, process, solution, equipment, machinery or service, including but not limited to fresh food packaging
      technologies, vacuum shrink, tray lidding, horizontal flow packaging, vertical flow packaging, thermoforming; (ii) any protective packaging product, process, solution, equipment, machinery, or service, including but not limited to inflatables,
      protective and cushioned wraps, mailers and shipping bags, foam packaging, corrugated packaging, corrugated packaging, automated packaging systems, paper products, or loose fill; (iii) any shrink packaging product, process, service, equipment or
      machinery, including but not limited to performance shrink films, shrink sleeve labels; (iv) any specialty materials product, process, solution, equipment, machinery or service, including but limited to alternative energy, cold chain solutions,
      consumer products, automotive, composite processing, vacuum insulation panels, or personal protection; (v) any medical applications packaging product, process, solution or service, including but not limited to custom thermoformed products, medical
      films or pharmaceutical films; (vi) any cleaning, sanitation, and hygiene product, process, solution, equipment, machinery or service sold to or applied in the following sectors: food and beverage, hospitality, healthcare, retail, food services or
      building service contractors, and such other sectors as the Company may be serving at the time of the Participant&#8217;s termination of employment with the Company; (vii) any other product, process, solution, equipment, machinery, or service, in each case
      that is similar to (or would serve as a substitute for) and competitive with any of the above described products, processes, solutions, equipment, machinery, or services; (viii) any other product, process, solution, equipment, machinery, or service,
      in each case that the Company, Parent and/or Affiliate is researching, developing, manufacturing, distributing, selling and/or providing at the time of the Participant&#8217;s termination of employment with the Company; and/or (ix) any product, process,
      solution, equipment, machinery, or service that is similar to (or would serve as a substitute for) and competitive with any product, process, solution, equipment, machinery, or service that the Company, Parent and/or Affiliate is researching,
      developing, manufacturing, distributing, selling and/or providing at the time of the Participant&#8217;s termination of employment with the Company; and (b) which the Participant worked in conjunction with or obtained any trade secret or other Confidential
      Information about at any time during the two (2) years immediately preceding the termination of the Participant&#8217;s employment with the Company.</div>
    <div>&#160;</div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-3</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(2) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Competing Organization</font>&#8221; is defined as
      any organization that researches, develops, manufactures, markets, distributes and/or sells one or more Competing Products or has plans to research, develop, manufacture, market, distribute, and/or sell one or more Competing Products. A Competing
      Organization is diversified if (a) it controls or is in common control of entities which conduct business in an industry other than food and/or beverage packaging, protective packaging, shrink packaging, specialty materials, medical applications
      packaging, or cleaning, sanitation and hygiene products in the food and beverage, hospitality, healthcare, retail, food services or building service contractors industries, or (b) operates multiple business divisions, units, lines or segments some of
      which do not involve any Competing Products.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(3) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Prohibited Capacity</font>&#8221; is defined as: (i)
      the same or similar capacity or function in which the Participant worked for the Company at any time during the last two (2) years of the Participant&#8217;s employment; (ii) any executive or managerial capacity; (iii) any sales or sales management
      capacity; (iv) any research or research management capacity; and/or (v) any other capacity in which the Participant&#8217;s knowledge of Confidential Information and/or Inventions would provide a competitive advantage to a Competing Organization.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(4) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Restricted Geographic area</font>&#8221; is defined
      as the Continental United States and all other countries, territories, or states in which the Company is doing business or is selling its products at the time of termination of the Participant&#8217;s employment with the Company, and includes the
      countries, states, and/or provinces in which the Participant worked for the Company during the two (2) years immediately preceding the termination of the Participant&#8217;s employment with the Company.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(5) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Non-Competition Period</font>&#8221; is defined (a)
      the period that the Participant is employed by the Company; and (b) a post-employment period of eighteen (18) months after the Participant&#8217;s last day of employment with the Company, unless otherwise extended by the Participant&#8217;s breach of this
      Exhibit B.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(6) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Customer</font>&#8221; is defined as any distributor,
      entity or person with respect to whom, as of the termination of the Participant&#8217;s employment with the Company or at any time during the two (2) years prior to such employment termination, the Company sold or provided any products and/or services.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(7) &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman'; font-weight: bold;">Active Prospect</font>&#8221; is defined as any
      person or entity that the Participant identified, marketed to, and/or held discussions with regarding the research, development, manufacture, distribution, and/or sale of any of the Company&#8217;s products or services at any time during the last twelve
      (12) months of the Participant&#8217;s employment with the Company, and/or any person or entity that the Company identified, marketed to, and/or held discussions with regarding the research, development, manufacture, distribution, and/or sale of any
      Company&#8217;s products or services at any time during the last twelve (12) months of the Participant&#8217;s employment with the Company.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(b) <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Restrictive Covenants</u></font>. During the Non-Competition Period, the
      Participant agrees to be bound by each of the following independent and divisible restrictions:</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(1) The Participant will not, within the Restricted Geographic Area, be employed by, work for, consult with, provide services to, or
      lend assistance to any Competing Organization in a Prohibited Capacity.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(2) The Participant will not be employed by, work for, consult with, provide services to, or lend assistance to any Competing
      Organization in any capacity if it is likely that as part of such capacity, the Participant would inevitably use and/or disclose any of the Company&#8217;s trade secrets or other Confidential Information.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(3) The Participant may be employed by, work for, consult with, provide services to, or lend assistance to any Competing Organization
      provided that: (i) the Competing Organization&#8217;s business is diversified; (ii) the part of the Competing Organization&#8217;s diversified business with which the Participant will be affiliated is not the same part of the Company&#8217;s business with which the
      Participant was affiliated during the last two (2) years of the Participant&#8217;s employment with the Company; (iii) the Participant&#8217;s affiliation with the Competing Organization does not involve any Competing Products; (iv) the Participant provides the
      Company with a written description of the Participant&#8217;s anticipated activities on behalf of the Competing Organization which includes, without limitation, an assurance satisfactory to the Company that the Participant&#8217;s affiliation with the Competing
      Organization does not constitute a Prohibited Capacity; and (v) the Participant&#8217;s affiliation with the Competing Organization would not likely cause the Participant to inevitably use and/or disclose any of the Company&#8217;s trade secrets or other
      Confidential Information.</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-4</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>

    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(4) The Participant will not be employed by, work for, consult with, provide services to or lend assistance to any Customers or Active
      Prospects in the Restricted Geographic Area in a capacity or role that involves any Competing Products and is competitive with the business of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(5) The Participant will not provide, sell, market, assist in the provision, selling or marketing of, or attempt to provide, sell or
      market any Competing Products to any of the Company&#8217;s Customers located in Restricted Geographic Area or otherwise solicit or communicate with any of the Company&#8217;s Customers located in the Restricted Geographic Area for the purpose of selling,
      marketing or providing, assisting in the provision, selling or marketing of, or attempting to sell, market or provide any Competing Products.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(6) The Participant will not provide, sell, market, attempt to provide, sell or market, or assist any person or entity in the sale or
      provision of, any Competing Products to any of the Company&#8217;s Customers with respect to whom, at any time during the two (2) years immediately preceding the termination of the Participant&#8217;s employment with the Company, the Participant had any sales or
      service contact on behalf of the Company, the Participant had any business contact on behalf of the Company, the Participant had any sales or service responsibility (including without limitation any supervisory or managerial responsibility) on behalf
      of the Company, or the Participant had access to, or gained knowledge of, any Confidential Information concerning the Company&#8217;s business with such customer, or otherwise solicit or communicate with any such customers for the purposes of selling or
      providing any Competing Products.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(7) The Participant will not provide, sell, market, attempt to provide, sell or market, or assist any person or entity in the sale or
      provision of, any Competing Products to any of the Company&#8217;s Active Prospects, or otherwise solicit or communicate with any of the Company&#8217;s Active Prospects for the purpose of selling or providing any Competing Products.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(8) The Participant will not urge, induce or seek to induce any of the Company&#8217;s independent contractors, subcontractors,
      distributors, brokers, consultants, sales representatives, customers, vendors, suppliers or any other person or entity with whom the Company has or has had a business relationship during the twelve (12) months immediately preceding the termination of
      the Participant&#8217;s employment with the Company to terminate their relationship with, or representation of, the Company or to cancel, withdraw, reduce, limit or in any manner modify any such person&#8217;s or entity&#8217;s business with, or representation of, the
      Company.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(9) The Participant will not solicit, recruit, hire, employ, engage or retain, or assist any Competing Organization in the
      solicitation, recruitment, hiring, employment, engagement or retention of, any of the Company&#8217;s distributors, sales representatives, or consultants located in the Restricted Geographic Area, for any competitive purpose.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(10) The Participant will not employ, engage in personal service or favor (whether or not compensated), solicit for employment, advise
      or recommend to any other person or entity that such person or entity employ, or solicit for employment, any individual now or hereafter employed by the Company, or otherwise induce or entice any such employee to leave his/her employment with the
      Company to work for, consult with, provide services to, or lend assistance to any Competing Organization.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(11) The Participant agrees that the divisible covenants contained in this Exhibit B prohibit the Participant from engaging in the
      restricted activities directly or indirectly, whether on the Participant&#8217;s behalf or on behalf of or for the benefit of any other person or entity, including for the Participant&#8217;s benefit, and that all of the covenants restrict the Participant from
      engaging in activities for a competitive purpose.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; margin-left: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">(12) The Non-Competition Period shall not expire during any period in which the Participant is in violation of any of the restrictive
      covenants set forth herein, and all restrictions shall automatically be extended by the period the Participant was in violation of any such restrictions.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">9. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Reasonableness of Terms</u></font>. The Participant acknowledges and agrees that
      the restrictive covenants contained in this Exhibit B are reasonably necessary to protect the Company&#8217;s, Parent&#8217;s and Affiliates&#8217; legitimate interests in Confidential Information, Inventions, and goodwill. Additionally, the Participant acknowledges
      and agrees that the restrictive covenants are reasonable in all respects, including, but not limited to, temporal duration, scope of prohibited activities and geographic area. The Participant further acknowledges and agrees that the restrictive
      covenants set forth in this Exhibit B will not pose any hardship on the Participant and that the Participant will reasonably be able to earn an equivalent livelihood without violating any provision of this Exhibit B.</div>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-5</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">10. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Severability, Modification of Restrictions</u></font>. The covenants and
      restrictions in this Exhibit B are separate and divisible, and to the extent any clause, portion or section of this Exhibit B is determined to be unenforceable or invalid for any reason, the Company and the Participant acknowledge and agree that such
      unenforceability or invalidity shall not affect the enforceability or validity of the remainder of this Exhibit B. If any particular covenant, provision or clause of this Exhibit B is determined to be unreasonable or unenforceable for any reason,
      including, without limitation, the temporal duration, scope of prohibited activity, and/or geographic area covered by any non-competition, non-solicitation, non-disparagement or non-disclosure covenant, provision or clause, the Company and the
      Participant acknowledge and agree that such covenant, provision or clause shall automatically be deemed reformed such that the contested covenant, provision or clause will have the closest effect permitted by applicable law to the original form and
      shall be given effect and enforced as so reformed to whatever extent would be reasonable and enforceable under applicable law. The parties agree that any court interpreting the provisions of this Exhibit B shall have the authority, if necessary, to
      reform any such provision to make it enforceable under applicable law.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">11. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Remedies</u></font>. The Participant acknowledges that a breach or threatened
      breach by the Participant of this Exhibit B will give rise to irreparable injury to the Company and the money damages will not be adequate relief for such injury. Accordingly, the Participant agrees that the Company shall be entitled to obtain
      injunctive relief, including, but not limited to, temporary restraining orders, preliminary injunctions and/or permanent injunctions, without having to post any bond or other security, to restrain or prohibit such breach or threatened breach, in
      addition to any other legal remedies which may be available. In addition to all other relief to which it shall be entitled, the Company shall be entitled to continue to enforce this Exhibit B and recover from the Participant all litigation costs and
      attorneys&#8217; fees incurred by the Company in any action or proceeding relating to this Exhibit B in which the Company prevails in any respect, including but not limited to, any action or proceeding in which the Company seeks enforcement of this Exhibit
      B or seeks relief from the Participant&#8217;s violation of this Exhibit B.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">12. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Survival of Obligations</u></font>. The Participant acknowledges and agrees that
      the Participant&#8217;s obligations under this Exhibit B, including, without limitation, the Participant&#8217;s non-disclosure and non-competition obligations, shall survive the termination of the Participant&#8217;s employment with the Company, whether or not such
      termination is with or without cause or whether or not it is voluntary or involuntary. The Participant further acknowledges and agrees that: (a) the Participant&#8217;s non-disclosure, non-disparagement, non-solicitation and non-competition covenants set
      forth in Sections 3 and 8 of this Exhibit B shall be construed as independent covenants and that no breach of any contractual or legal duty by the Company shall be held sufficient to excuse or terminate the Participant&#8217;s obligations under Sections 3
      and 8 of this Exhibit B or to preclude the Company from obtaining injunctive relief or other remedies for the Participant&#8217;s violation or threatened violation of such covenants, and (b) the existence of any claim or cause of actions by the Participant
      against the Company, whether predicted on this Exhibit B or otherwise, shall not constitute a defense to the Company enforcement of the Participant&#8217;s obligations under Sections 3 and 8 of this Exhibit B.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">13. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Governing Law and Choice of Forum</u></font>. This Exhibit B shall be construed
      and enforced in accordance with the laws of the State of North Carolina, notwithstanding any state&#8217;s choice-of-law rules to the contrary. The parties hereby submit to the jurisdiction of the State and Federal Courts in the State of North Carolina and
      waive any right to challenge or otherwise object to personal jurisdiction or venue, in any action commenced or maintained in such courts. Language translations aside, the English version shall govern.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">14. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Successors and Assigns</u></font>. The Company shall have the right to assign this
      Exhibit B, and, accordingly, this Exhibit B shall inure to the benefit of, and may be enforced by, any and all successors and assigns of the Company, including without limitation by asset assignment, stock sale, merger, consolidation or other
      corporate reorganization, and shall be binding on the Participant, the Participant&#8217;s executors, administrators, personal representatives or other successors in interest. The services to be provided by the Participant to the Company are personal to
      the Participant, and the Participant shall not have the right to assign the Participant&#8217;s duties under this Exhibit B.</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" class="BRPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-6</font></div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">15. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Modification</u></font>. This Exhibit B may not be amended, supplemented, or
      modified except by a written document signed by both the Participant and a duly authorized officer of the Company.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">16. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>No Waiver</u></font>. The failure of the Company to insist in any one or more
      instances upon performance of any of the provisions of this Exhibit B or to pursue its rights hereunder shall not be construed as a waiver of any such provisions or the relinquishment of any such rights.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">17. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Counterparts</u></font>. This Exhibit B may be executed in counterparts, each of
      which shall be deemed an original, but both of which when taken together will constitute one and the same agreement.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">18. <font style="font-size: 10pt; font-family: 'Times New Roman';"><u>Entire Agreement</u></font>. This Exhibit B constitutes the entire agreement of
      the parties with respect to the subjects specifically addressed herein, and supersedes any prior agreements, understandings or representations, oral or written, on the subjects addressed herein. Notwithstanding the foregoing, to the extent the
      Participant has an existing non-competition, confidentiality, and/or non-solicitation agreement in favor of the Company and has breached or violated the terms thereof, the Company may continue to enforce its rights and remedies under and pursuant to
      such existing agreement.</div>
    <div>&#160;</div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman'; font-size: 10pt;">The Participant&#8217;s signature below indicates that the Participant has read Exhibit B and the Plan in their entirety, the Participant understands what the
      Participant is signing, and is signing it voluntarily. The Participant agrees that the Company advised the Participant to consult with an attorney prior to signing this Exhibit B.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z3272238766cd44b881add8f34e958e94" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;PARTICIPANT&#8221;</div>
          </td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">&#8220;COMPANY&#8221;</div>
          </td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="3">&#160;</td>
          <td style="width: 5%; vertical-align: top;">&#160;</td>
          <td style="width: 43%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0); width: 4%;">&#160;</td>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 44%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>
        <tr>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date:</div>
          </td>
          <td style="width: 44%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 4%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 5%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; color: #000000; font-family: 'Times New Roman'; font-size: 10pt;">Date:</div>
          </td>
          <td style="width: 43%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div><br>
    </div>
    <div style="text-align: center;"><font style="font-family: 'Times New Roman'; font-size: 8pt; font-weight: normal; font-style: normal;">B-7</font></div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>see-20240530.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<xs:schema targetNamespace="http://sealedair.com/20240530" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:see="http://sealedair.com/20240530" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:srt-types="http://fasb.org/srt-types/2023">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="see-20240530_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="see-20240530_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://sealedair.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>see-20240530_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract" xml:lang="en-US" id="dei_CoverAbstract">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract" xlink:title="label: CoverAbstract to dei_CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType" xml:lang="en-US" id="dei_DocumentType">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType" xlink:title="label: DocumentType to dei_DocumentType" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications" xml:lang="en-US" id="dei_WrittenCommunications">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications" xlink:title="label: WrittenCommunications to dei_WrittenCommunications" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial" xml:lang="en-US" id="dei_SolicitingMaterial">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer" xml:lang="en-US" id="dei_PreCommencementTenderOffer">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag" xml:lang="en-US" id="dei_AmendmentFlag">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag" xlink:title="label: AmendmentFlag to dei_AmendmentFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus" xml:lang="en-US" id="dei_DocumentFiscalYearFocus">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate" xml:lang="en-US" id="dei_DocumentPeriodEndDate">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName" xml:lang="en-US" id="dei_EntityRegistrantName">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey" xml:lang="en-US" id="dei_EntityCentralIndexKey">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber" xml:lang="en-US" id="dei_EntityFileNumber">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber" xlink:title="label: EntityFileNumber to dei_EntityFileNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1" xml:lang="en-US" id="dei_EntityAddressAddressLine1">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2" xml:lang="en-US" id="dei_EntityAddressAddressLine2">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3" xml:lang="en-US" id="dei_EntityAddressAddressLine3">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown" xml:lang="en-US" id="dei_EntityAddressCityOrTown">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince" xml:lang="en-US" id="dei_EntityAddressStateOrProvince">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry" xml:lang="en-US" id="dei_EntityAddressCountry">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode" xml:lang="en-US" id="dei_EntityAddressPostalZipCode">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode" xml:lang="en-US" id="dei_CityAreaCode">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode" xlink:title="label: CityAreaCode to dei_CityAreaCode" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber" xml:lang="en-US" id="dei_LocalPhoneNumber">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle" xml:lang="en-US" id="dei_Security12bTitle">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle" xlink:title="label: Security12bTitle to dei_Security12bTitle" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag" xml:lang="en-US" id="dei_NoTradingSymbolFlag">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol" xml:lang="en-US" id="dei_TradingSymbol">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol" xlink:title="label: TradingSymbol to dei_TradingSymbol" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName" xml:lang="en-US" id="dei_SecurityExchangeName">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>see-20240530_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by Broadridge PROfile 24.3.1.5224 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://sealedair.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="see-20240530.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://sealedair.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentType" xlink:title="presentation: CoverAbstract to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="AmendmentFlag" xlink:title="presentation: CoverAbstract to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: CoverAbstract to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalYearFocus" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: CoverAbstract to DocumentFiscalPeriodFocus" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityFileNumber" xlink:title="presentation: CoverAbstract to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityRegistrantName" xlink:title="presentation: CoverAbstract to EntityRegistrantName" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityCentralIndexKey" xlink:title="presentation: CoverAbstract to EntityCentralIndexKey" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: CoverAbstract to EntityIncorporationStateCountryCode" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: CoverAbstract to EntityTaxIdentificationNumber" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine1" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine2" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: CoverAbstract to EntityAddressAddressLine3" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: CoverAbstract to EntityAddressCityOrTown" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: CoverAbstract to EntityAddressStateOrProvince" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressCountry" xlink:title="presentation: CoverAbstract to EntityAddressCountry" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: CoverAbstract to EntityAddressPostalZipCode" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="CityAreaCode" xlink:title="presentation: CoverAbstract to CityAreaCode" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="LocalPhoneNumber" xlink:title="presentation: CoverAbstract to LocalPhoneNumber" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="Security12bTitle" xlink:title="presentation: CoverAbstract to Security12bTitle" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="TradingSymbol" xlink:title="presentation: CoverAbstract to TradingSymbol" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: CoverAbstract to NoTradingSymbolFlag" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SecurityExchangeName" xlink:title="presentation: CoverAbstract to SecurityExchangeName" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: CoverAbstract to EntityEmergingGrowthCompany" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="WrittenCommunications" xlink:title="presentation: CoverAbstract to WrittenCommunications" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="SolicitingMaterial" xlink:title="presentation: CoverAbstract to SolicitingMaterial" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementTenderOffer" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: CoverAbstract to PreCommencementIssuerTenderOffer" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1.1.u2</span><table class="report" border="0" cellspacing="2" id="idm140540208652176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 30, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 30,  2024<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-12139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SEALED AIR CORP/DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001012100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">65-0654331<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2415 Cascade Pointe Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28208<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">980<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">221-3235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.10 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SEE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>8
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
M.7\N?<^E[[GT/:'2MS<C?6?!TXM;WD9N6\3[KC':US0N*&-7<LW(QU2ODRG8
M.9_ [/UH/I[Q[?K9)(2OFEDM(Q:02X&S022X_(O*\"K$">AD6R4)RU3393>*
M$IY"&V[I4_5*E=?EK[DHN#Q;Y.FOH70^+,_Y/%_GM,T+,T.W<DOJMI2^M28X
M2O2QS'!.'LL,.V<\DAVV=Z =-?OV77;D(Z4P4Y=#N!I"O@-MNIW<.CB>F)&Y
M"M-2D&_#^>G%>!KB.=D$N7V85VWGV-'1^^?!4;"C[SR6'<>(\J(A[J&&F,_#
M0X=Y>U^89Y7&4#04;6RL)"Q&MV"XU_$L%.!D8"V@!X.O40+R4E5@,5O& RN0
MHGQ,C$7H<.>77%_CT9+CVZ9EM6ZO*7<9;2)2.<)IF!-GJ\K>9;'!51W/55OR
ML+YJ/;053L_^6:W(GPP13A8+$DACE!>F2J+S&5.^YRM)Q%4XOT4SMA*7&+SC
MYL=Q3E.X$G:V#P(RN;LYJ7IE,6>F\M\M# DL6XA9$N)-7>W5YYN<KGHB=OJ7
M=\%@\OUPR4</Y3OG7_1=0ZY^]MWC^FZ3.TA,G'G%$0%T10(CE1P&%A<RY%#N
MDI &$P'-E,E$\ *"9*8<@)CZ"[WR#+DI%<ZM/CE_12R#ADY>TB42%(JP# 4A
M%W+C[^^3:G>,U_HL@6V$5#)DU1?*0XG!/3-R0]A4)?.NVB8+A=OB5,V[&KXF
M8$O#>FZ=+2?_VU[4/;07/4;SHYG@'K.'<YMZN,)%K/]8UA[Y,M\Y<-LZW@->
MYA,L0Z1^P7V*BH 1JV*^NJ]/^26<.[1[\8$@F_S6VZ3VW> ,?-2K6J5D*Q$_
M2P=\'Y(&8XQ;]#1?CQ1BK::QK<;:,0QY@%CS#*%F.-^'19H:,]6+K#F-"F]!
MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
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MBPO,QJ@)5WV"XEY^R!<9OX<KEB[YR>;:(/3\UPPC\JNVX)_5%L8)5TN;HM]
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M4$L! A0#%     @ E$;$6&TSTA7O    *P(  !$              ( !KP
M &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ E$;$6)E<G",0!@  G"<
M !,              ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M    " "41L18UEM^.U4$  "7$   &               @($."   >&PO=V]R
M:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ E$;$6)^@&_"Q @  X@P
M  T              ( !F0P  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " "4
M1L18EXJ[',     3 @  "P              @ %U#P  7W)E;',O+G)E;'-0
M2P$"% ,4    " "41L18'#AEZC\!   \ @  #P              @ %>$
M>&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ E$;$6"0>FZ*M    ^ $  !H
M             ( !RA$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L!
M A0#%     @ E$;$6&60>9(9 0  SP,  !,              ( !KQ(  %M#
G;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  ^1,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1.1.u2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ef20030540_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sealedair.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:EntityRegistrantName -  ef20030540_8k.htm 11</Log>
  </Logs>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ef20030540_8k.htm">ef20030540_8k.htm</File>
    <File>see-20240530.xsd</File>
    <File>see-20240530_lab.xml</File>
    <File>see-20240530_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ef20030540_8k.htm": {
   "nsprefix": "see",
   "nsuri": "http://sealedair.com/20240530",
   "dts": {
    "inline": {
     "local": [
      "ef20030540_8k.htm"
     ]
    },
    "schema": {
     "local": [
      "see-20240530.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/currency/2023/currency-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/exch/2023/exch-2023.xsd",
      "https://xbrl.sec.gov/naics/2023/naics-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd",
      "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "see-20240530_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "see-20240530_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 29,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://sealedair.com/role/DocumentAndEntityInformation",
     "longName": "000100 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c20240530to20240530",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20030540_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c20240530to20240530",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ef20030540_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://sealedair.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-24-028719-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-24-028719-xbrl.zip
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M[PI*I-0-.8 I#*',0T?M = '/@\H8\5SIE[(GYNZ' IE1U7_4FK_H-F$=)!
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MCNJ;CJTYIN%8MM'T;9BYX_@K,"+'G@E*.5IZ6*B4._'"P\7/,1#-+8)VQMD
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M#L(A-*&BR].R.(Z&"9ZCC21:9F,&_3YG\I9#..P/<(#3/9WLZ617Z(2B.YB
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M<%Y/ZN0"1%!([FKDCR ,@^1-D]K6 8HIU+: 0=]A)7NT>$5@RG22;P,O_B=
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M^B.$)T%5(O.T,$O8,CID4J30^!'C34P*=X[:Q;TI<QB'3W53P6RR.<I&](F
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MI+#A6CU2VA3L)/VU?^.\H[NN3<-V-7Y'SQ??37\EX[<IYQ^9<;,'6E+SQG:
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M!U[%. LV)<1RM/X2=#PJ(AW"3TY3.6-(Z,/T23_;5-B),*2;EI]^?884"O6
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M0P0ML,PHZ38"4]M6B/@^,YPH "P.+\;>?+G7M3;!J$6V;.9]/MLQ8S@CO>R
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M^5?%6YAIB_:I?T)']9.(RLJLOU1OK!W2;IY+(I]5_.0\.\]RF\@=YGL_>8B
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MG1U]]]W1T9=,3GW]?_[SS8LW'Z*SJ13EO1>\9Y\G2^K7R]>_3U$^G!S?">G
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M#C6F*DD)(-']F0K?^#>-7F,/5== U;8&ZI7)L0F>B:-_';\_/CN6KN@5Z'M
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M9 ;=^)&$_^@-J .SXD5!H"W&:<=/O,6LHE.08[ %WY_'&UEK0GS)H*88@S=
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MTS 0?4?B'TS>G4O3(EIM=P7:7;32PJ(%)-Z0ZTQ;"]<)MDO;O\=VZC2];M/
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M6SWS43@O1JV3 P-/^C9D&D1WI-!R0^YXW;&4Q*007OV&"LP),C^6N0%ZA[<
MX*G<2*-I=[>,U_I"[G--.):VQ#3&Y2\HY,]U^,U\7KM/;@:JA?(!X>G>FE:#
M_KX\V@>0^UQ&_:,\7V/>V@U.N-T3%CAX9S11/,P?EFS:)2_MI9V&M24<BP/R
M=^?;B/PC?Z?]Z7]02P$"% ,4    " "41L18'*&A_'(6  "*FP  $0
M        @ $     968R,# S,#4T,%\X:RYH=&U02P$"% ,4    " "41L18
M4,&R3%5@  "%3@( %0              @ &A%@  968R,# S,#4T,%]E>#$P
M+3$N:'1M4$L! A0#%     @ E$;$6(!?$B1# P  .0\  !
M ( !*7<  '-E92TR,#(T,#4S,"YX<V102P$"% ,4    " "41L18!_#EBGH(
M   P5@  %               @ &:>@  <V5E+3(P,C0P-3,P7VQA8BYX;6Q0
M2P$"% ,4    " "41L18LB6DR]P%  #R/@  %               @ %&@P
J<V5E+3(P,C0P-3,P7W!R92YX;6Q02P4&      4 !0!$ 0  5(D

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>ef20030540_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="see-20240530.xsd" xlink:type="simple"/>
    <context id="c20240530to20240530">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001012100</identifier>
        </entity>
        <period>
            <startDate>2024-05-30</startDate>
            <endDate>2024-05-30</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20240530to20240530"
      id="Fact_cd050f34584143cb822fcb7435edfdec">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName
      contextRef="c20240530to20240530"
      id="Fact_7f45b632db45453a92f028832bb8776e">SEALED AIR CORP/DE</dei:EntityRegistrantName>
    <dei:EntityCentralIndexKey
      contextRef="c20240530to20240530"
      id="Fact_4e6d4ad0a45844988d6e006f1d3961b4">0001012100</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20240530to20240530"
      id="Fact_cc29206ea04f4902b0f2e80083f9ef23">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20240530to20240530"
      id="Fact_f4cd9a6b3a6f47bbac3c4cfe68a7853d">2024-05-30</dei:DocumentPeriodEndDate>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20240530to20240530"
      id="Fact_194e8c3f3c324d029b913fb5272438f7">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20240530to20240530"
      id="Fact_e9ef2d9424a647ffb74557943e9cb84e">1-12139</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20240530to20240530"
      id="Fact_bee8c5de846740818e51ee63e4bd8099">65-0654331</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20240530to20240530"
      id="Fact_72b4b5052eca40899cfffe80ce6a7b4c">2415 Cascade Pointe Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="c20240530to20240530"
      id="Fact_51889b36dffa4ab78cff6592a440201a">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20240530to20240530"
      id="Fact_f56669ae1cfc4a5497ddadc983b674d1">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20240530to20240530"
      id="Fact_8b7276c613054df180fd85109bfbf029">28208</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20240530to20240530"
      id="Fact_dc777792a90f498194395837f882199f">980</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20240530to20240530"
      id="Fact_a407cae3a6924a90ae700a7b53c44ad6">221-3235</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="c20240530to20240530"
      id="Fact_302e5b08350f4f319889691605e3261a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20240530to20240530"
      id="Fact_e43be113d2c4468c8bf3f69e2faa34c0">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20240530to20240530"
      id="Fact_d097f2c46a0b472b8f7285fc4415d6e3">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20240530to20240530"
      id="Fact_dc3d0b9229d94fdba478bff6297efa18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20240530to20240530"
      id="Fact_8288a8a92a6e434da7b97b9f52bbd80a">Common Stock, par value $0.10 per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20240530to20240530"
      id="Fact_864db98ed23047c98f532b3b636ec99c">SEE</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20240530to20240530"
      id="Fact_6042107e52de4d3bba58cf8f39601261">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20240530to20240530"
      id="Fact_94d58b96781a48358132766b144e275a">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
